Clinical Trials Logo

Filter by:
NCT ID: NCT03264729 Completed - Plantar Fasciopathy Clinical Trials

The Acute Effect of Isotonic Versus Isometric Exercise Versus Walking on Pain in Individuals With Plantar Fasciopathy

Start date: August 24, 2017
Phase: N/A
Study type: Interventional

This study investigates the acute effect of isotonic versus isometric exercise versus walking on pain in individuals with plantar heel pain and an ultrasound-diagnosed plantar fasciopathy. The hypothesis is that isometric exercise will induce greater participant rated pain relief than isotonic exercise and walking during aggravating activity.

NCT ID: NCT03264365 Completed - Clinical trials for Intensive Care Unit Syndrome

The Effectiveness of a Post-ICU Recovery Program on Relatives

RAPIT-II
Start date: December 15, 2012
Phase: N/A
Study type: Interventional

Relatives of intensive care patients are at risk of developing symptoms of anxiety, depression and post-traumatic stress disorder resulting in impaired health-related quality of life (HRQOL). Recovery programs have been tested, but its effectiveness is sparse. The hypothesis is that relatives to former intensive care patients will improve their HRQOL one year after intensive care. We want to determine whether relatives to former intensive care patient's benefits from a recovery programme with improved HRQOL, Sense Of Coherence (SOC) and symptoms of anxiety, depression and PTSD compared to standard care one year after intensive care.

NCT ID: NCT03263884 Completed - Pain Relief Clinical Trials

Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The main purpose of the study is to assess the mechanisms of repeated sessions of repetitive trancranial magnetic stimulation (rTMS) applied on left dorsolateral prefrontal cortex on the development of pain in a prolonged muscle pain model.

NCT ID: NCT03263234 Completed - Clinical trials for Elderly Housing Residents With Frailty or Dementia

Circadian Adjusted LED Light's Effect in People Living in Elderly Housing

Lightel
Start date: September 29, 2017
Phase: N/A
Study type: Interventional

Europe is undergoing a demographic change with a rapidly growing population of 65 years+. This challenges municipalities and hospitals as the ageing citizens need care and treatment due to an age-related decline in physical and mental capacity. Therefore municipalities are experiencing a growing need for sufficient and customized housing, which can support the elderly citizens in sustaining well-being and health along with preventing functional decline. Well-fare technologies, such as Circadian adjusted LED-based lighting (CALED), are suggested as a remedy for this. To obtain proper visual sharpness and better contrast, people of older age require heightened light levels due to age-related failing vision. Furthermore, inappropriate light at night disrupts not only sleep but also the timing of the circadian rhythm, with negative consequences on cognition and emotions. Therefore CALED is being increasingly considered for use in hospitals and elderly housing because of its wide spectrum of wavelengths, good contrast and fast switching, and possibility to support a normalised circadian rhythm. Lighting based on LED has been shown to improve the quality of sleep and to improve well-being in the elderly. However, it is not known whether CALED mimicking a normal circadian rhythm has the same benefits for elderly persons with frailty or dementia. The investigators therefore want to test the effects of CALED in elderly people with frailty and mobility disabilities and/or dementia living in elderly housing. The investigators hypothesise that CALED can improve sleep and well-being in both elderly with frailty and dementia.

NCT ID: NCT03262935 Completed - Clinical trials for Metastatic Breast Cancer

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

TULIP
Start date: December 15, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that SYD985 [(vic-)trastuzumab duocarmazine] is superior to physician's choice in prolonging progression free survival.

NCT ID: NCT03261622 Completed - Fecal Incontinence Clinical Trials

Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective

SNS
Start date: November 1, 2016
Phase: N/A
Study type: Interventional

Sacral nerve stimulation (SNS) has over the last 20 years been recognised as an efficient treatment option for faecal incontinence (FI). In a selected patient group we have evidence that 90% of patients will have a successful test period (≥50% reduction in incontinence episodes). If preoperative there is motor response on at least 3 out of 4 poles on the lead, at a threshold ≤1.5 mAMP. Hypotheses In a selected patient group suffering from faecal incontinence a one-stage permanent implant will be possible. The functional results will be improved as more time can be spent finding the optimal pacemaker settings as the risk of infection is reduced compared to the stage implant. One-Stage implantation gives the opportunity to test the amount of placebo effect with SNS. During the first 3 months postoperative patients will be randomized to either stimulation amplitude set at 90% of sensory threshold (control group) or 3 periods of stimulation at 0.05v (placebo), 50% and 90% of sensory threshold. Patients are randomized in a 1 to 2 pattern. After the initial 3 months the stimulation amplitude is increased to sensory threshold. After six months the project ends and the number of patients achieving the 50% improvement in incontinence episodes are evaluated.

NCT ID: NCT03259074 Completed - Clinical trials for Ankylosing Spondylitis

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)

SURPASS
Start date: November 30, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the impact of secukinumab on the progression of structural damage in the spine, as measured by the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) in patients with Ankylosing Spondylitis (AS).

NCT ID: NCT03258164 Completed - Clinical trials for Breast Hypoplasia and Facial Ageing

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Start date: March 22, 2017
Phase: Phase 3
Study type: Interventional

The purpose of the present study is to examine whether enrichment of a fat graft with autologous ex vivo expanded ASC injected into the breast tissue or face, both for cosmetic use, will significantly improve the results of conventional lipofilling and synthetic facial fillers, thereby being able to offer a safer, more natural and long-lasting alternative to current artificial solutions for cosmetic patients.

NCT ID: NCT03257787 Completed - Ileostomy - Stoma Clinical Trials

Evaluation of the Performance of a New Adhesive Strip

Start date: August 8, 2017
Phase: N/A
Study type: Interventional

This study investigates the performance of a new adhesive strip when impacted by output.

NCT ID: NCT03257774 Completed - Ileostomy - Stoma Clinical Trials

Evaluation of the Effect of Output on New Adhesives

Start date: July 19, 2017
Phase: N/A
Study type: Interventional

The study investigates the impanct real output has on the adhesion of a new adhesive